MRPL44 expression was identified as a predictor of lymph node metastasis in papillary thyroid carcinoma [5], and MRPL13 suppression was shown to be a key upstream regulator of OXPHOS dysfunction and hepatoma cell invasiveness [6]. The gene discussed is MRPL13; the disease is hepatocellular carcinoma.